Atezolizumab (Tecentriq) Concentrate from Germany
Atezolizumab is a humanized anti-PD-L1 monoclonal for bladder cancer. HTS 3002.15.00.11 for checkpoint immunological product.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Immunotherapy cold chain critical